Prevalence and determinants of chronic kidney disease among community-dwelling adults, 50 years and older in Ireland
Open Access
- 4 March 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 18 (3) , sfaf065
Abstract
Background: Using the Irish Longitudinal Study on Ageing (TILDA), we evaluated the prevalence and distribution of chronic kidney disease (CKD), and its determinants in order to identify risk groups for population health planning in Ireland. Methods: Data were analysed from Wave 1 (2009–2011) of the TILDA, a national cohort of participants aged 50+ years who had both plasma creatinine and cystatin C measured at baseline. Kidney function was estimated using the 2012 and 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. CKD was defined as estimated glomerular filtration rate <60 mL/min/1.73 m2. Multivariable logistic regression explored associations using adjusted odds ratios (OR). Results: Prevalence of CKD was significantly higher using the CKD-EPI 2012(Scr-CysC) compared with the CKD-EPI 2021(Scr-CysC) (14.7% vs 11.3%, respectively). The prevalence was highest in patients with cardiovascular disease (CVD) (33.9%), diabetes (28.0%), cancer (25.5%), urinary incontinence (23.7%), bone diseases (21.5%), hypertension (19.8%) and obesity (19.5%). In multivariable analysis, individuals with hypertension (OR 1.78), diabetes (OR 1.45), CVD (OR 1.43), cancer (OR 1.53), overweight (OR 1.37) and obesity (OR 2.33) experienced greater likelihood of CKD. In addition, individuals with a history of previous hospitalization (OR 1.50), free or subsidized healthcare (OR 1.31), and unemployed individuals (OR 1.86) were also significantly more likely to have CKD. Conclusion: Compared with the national average, the burden of CKD is far greater in older individuals with major chronic conditions and socioeconomic deprivation. The identification and targeting of these groups through national surveillance programmes is likely to yield substantial benefits from more effective disease management and proactive population health planning.Keywords
Funding Information
- Health Research Board (SDAP-2019-036)
- Midwest Kidney Education and Research Foundation
- Atlantic Philanthropies
This publication has 38 references indexed in Scilit:
- Prevalence of kidney disease in patients with different types of cancer or hematological malignancies: a cross-sectional studyInternational Urology and Nephrology, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Sex and gender differences in the management of chronic kidney disease and hypertensionJournal of Human Hypertension, 2023
- Prevalence of Obesity and CKD Among Adults in the United States, 2017-2020Kidney Medicine, 2022
- Obesity and chronic kidney disease: A current reviewObesity Science & Practice, 2022
- Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective AnalysisRheumatology and Therapy, 2021
- Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territoriesThe Lancet, 2018
- Reducing major risk factors for chronic kidney diseaseKidney International Supplements, 2017
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policyThe Lancet, 2017
- Cardiovascular risk factors in patients with chronic kidney diseaseNature Reviews Cardiology, 2009